✨ Free AI Report
Abcam Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Abcam Limited
Research Preview

Abcam Limited: Business Overview, Financials & Competitive Analysis

Abcam Limited is a life science company that focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company operates as a subsidiary of Da...

Analyst-debate audio for Abcam Limited

AskCyborg analysts argue the bull and bear cases for Abcam Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Abcam Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Established global leader in research antibodies and life science tools with strategic backing from Danaher, positioned for...

Read the full analyst-debate transcript →
Industry Life Science Reagents
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Abcam Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Abcam Limited Overview

Pro stress-test →

Abcam Limited is a life science company that focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company operates as a subsidiary of Danaher Corporation as of December 6, 2023. Abcam operates worldwide from 13 locations with 1,800 employees, of which 400 work in Research and Development.

Strategic Profile

Pro stress-test →

The company's principal products include primary and secondary antibodies, conjugated antibodies and conjugation kits, singleplex immunoassays, proteins and peptides including cytokines, edited cell lines and lysates, and various other products including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. In April 2026, Abcam announced SimpleStep Ignite™ ELISA, a next generation chemiluminescent immunoassay platform.

Competitive Landscape

Pro stress-test →

Abcam competes in the life science research tools and antibodies market against specialized reagent suppliers and larger diversified life sciences companies. Key competitors include providers of antibodies, assays, and protein research tools serving academic, pharmaceutical, and biotechnology customers. As a Danaher subsidiary, Abcam benefits from complementary product integration and cross-selling opportunities within Danaher's life sciences and diagnostics portfolio.

Industry Context

Abcam Limited operates in Life Science Reagents.

Key facts

Founded: 1998 · Headquarters: Cambridge, United Kingdom · Employees: 1,888 (as of April 2026) · Revenue: £361.7 million (2022); post-acquisition 2023-2026 financials not separately disclosed as Danaher subsidiary · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Abcam Limited.

+1 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Abcam Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Abcam Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Abcam Limited operates in Life Science Reagents. See how the rest of the sector scores on the Cyborg framework.

Browse Life Science Reagents research →
NEW · MCP server

Ask your AI assistant about Abcam Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Abcam Limited and its top competitor on Cyborg Score”
“What did Abcam Limited do this quarter?”
“Is Abcam Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Abcam Limited do?+
Abcam Limited is a life science company that focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company operates as a subsidiary of Da...
What is Abcam Limited's Cyborg Score?+
Abcam Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Abcam Limited's main competitors?+
Named competitors include Antibodies and Research Reagents, Antibodies and Assays, Antibodies and Proteins. The full competitive landscape is in the AskCyborg report.
How can I get the full Abcam Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Abcam Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Abcam Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual